Clinical trial
Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for…
NCT02153229 · Abramson Cancer Center at Penn Medicine, Other · Active, not recruiting
Key facts
| NCT number | NCT02153229 |
|---|---|
| Title | Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma |
| Official title | A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma |
| Acronym | MPM-PDT |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epitheliod Malignant Pleural Mesothelioma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Photodynamic Therapy, Radical Pleurectomy, Chemotherapy, Photofrin 2.0 mg/kg |
| Enrollment | 52 |
| Start date | Jun 2, 2014 |
| Primary completion | Dec 16, 2026 |
| Completion | Dec 1, 2027 |
| First posted | Jun 3, 2014 |
| Last update posted | Dec 26, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: